Insiders Shield Therapeutics plc

Equities

Market Closed - London S.E. Other stock markets 16:35:17 14/05/2024 BST			5-day change	1st Jan Change
2 ^GBX	+5.26%		+29.03%	-70.15%

05-10	Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-30	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	04-30	AN
Shield Therapeutics hires former Akili leader as new CFO	01-09	AN
Shield Therapeutics Names New CFO	01-09	MT
Shield Therapeutics Appoints Santosh Shanbhag as New CFO, Effective January 16, 2024	01-08	CI
Shield Therapeutics Chief Financial Officer Rudolf to leave	12/10/23	AN
Shield Therapeutics CFO to Step Down	12/10/23	MT
Aston Martin CEO ups stake; Alkemy's lithium deal	03/10/23	AN
UK's Shield Therapeutics Names Chief Commercial Officer	05/04/23	MT
Shield appoints Andy Hurley as chief commercial officer	05/04/23	AN
Shield Therapeutics plc Announces Appointment of Andy Hurley as Chief Commercial Officer, Effective 10 April 2023	05/04/23	CI
TRADING UPDATES: Mobile Tornado loses CEO; DeepVerge revenue jumps	09/01/23	AN
Shield Therapeutics : Names New Chief Medical Officer	27/09/21	MT
Shield Therapeutics : Jose A. Menoyo MD Appointed as Chief Medical Officer	27/09/21	PU
Shield Therapeutics plc Announces Management Changes	27/09/21	CI
Shield Therapeutics plc Announces Executive Changes, Effective June 1, 2021	28/05/21	CI
Shield Therapeutics plc Announces Board Changes	28/05/21	CI
Shield Therapeutics plc Announces Board Changes	10/05/21	CI
Shield Therapeutics plc Appoints Hans-Peter Rudolf as Chief Financial Officer	22/03/21	CI
Shield Therapeutics plc Appoints Christian Schweiger as Non-Executive Director	26/06/20	CI
Shield Therapeutics plc Announces Management Changes	26/05/20	CI

No results for this search